当3000亿资金涌向18A新股

氨基观察
24 Jul

氨基观察-创新药组原创出品作者 | 郑晓港股18A板块正上演现象级IPO。7月22日维立志博完成认购,数据显示其融资申购金额飙至惊人的3300亿港元,散户认购倍数超3000倍。在今年创新药行情持续火热的背景下,超额认购已不算新鲜事,但3300亿港元的资金体量,仍堪称现象级。目前其暗盘交易显示,股价已经大涨超过90%,总市值超130亿港元。这一盛况,再次见证了创新药行业正迎来新周期的关键节点。资本的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10